| Protocol Number |
Study Title |
|
SWOG S0802 |
A Randomized Phase II Trial of Weekly Topotecan with and without AVE0005 (Aflibercept) in Patients with Platinum Treated Extensive Stage Small Cell Lung Cancer (E-SCLC)
|
|
SWOG S0809 |
A Phase II Trial of Adjuvant Capecitabine and Gemcitabine Chemotherapy Followed by Concurrent Capecitabine and Radiotherapy in Extrahepatic Cholangiocarcinoma (EHCC |
|
SWOG S0816 |
A Phase II Trial of Response-Adapted Therapy of Stage III-IV Hodgkin Lymphoma using Early Interim FDG-PET Imaging
|
|
SWOG S0819 |
A Randomized, Phase III Study Comparing Carboplatin/Paclitaxel Or Carboplatin/ Paclitaxel/Bevacizumab With Or Without Concurrent Cetuximab In Patients With Advanced Non-Small Cell Lung Cancer (NSCLC)
|
|
SWOG S0826 |
A Phase II Study of SCH 727965 in Patients with Stage IV Melanoma |
|
SWOG S0904 |
Randomized Phase II Study of Docetaxel Followed by Vandetanib vs. Docetaxel Plus Vandetanib in Patients with Persistent or Recurrent Epithelial Ovarian, Fallopian Tube or Primary Peritoneal Carcinoma |
|
SWOG S0919 |
A Phase II Study of Idarubicin and Ara-C in Combination with Pravastatin for Relapsed Acute Myelogenous Leukemia (AML) |
|
SWOG S0941 |
Phase II Study of Sorafenib and Erlotinib in Patients with Advanced Gallbladder Carcinoma or Cholangiocarcinoma |
|
SWOG S9007 |
Cytogenetic Studies in Leukemia Patients |
|
SWOG S9245 |
Central Lymphoma Repository Tissue Procurement Protocol for Relapse or Recurrent Disease |
|
SWOG S9910 |
Leukemia Centralized Reference Laboratories And Tissue Repositories - Consent To Perform Cellular And Molecular Studies In Leukemia Patients |
|
URCC U1105 |
Prevention of Delayed Nausea
A Phase III Double-Blind Placebo-Controlled Clinical Trial
|
|
URCC UCCO 08106 (EXCAP) |
A Study of the Effects of Exercise on Cancer-Related Fatigue |
